JoVE Logo

Zaloguj się

Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.

W tym Artykule

  • Podsumowanie
  • Streszczenie
  • Wprowadzenie
  • Protokół
  • Wyniki
  • Dyskusje
  • Ujawnienia
  • Podziękowania
  • Materiały
  • Odniesienia
  • Przedruki i uprawnienia

Podsumowanie

Primary hepatocytes are a valuable tool to study liver response and metabolism in vitro. Utilizing commercially available reagents, an improved time- and labor-efficient protocol for mouse primary hepatocyte isolation was developed.

Streszczenie

Primary hepatocytes are used extensively in liver in vitro research, especially in glucose metabolism studies. A base technique has been adapted based on different needs, like time, labor, cost, and primary hepatocyte usage, resulting in various primary hepatocyte isolation protocols. However, the numerous steps and time-consuming reagent preparations in primary hepatocyte isolation are major drawbacks for efficiency. After comparing different protocols for their pros and cons, the advantages of each were combined, and a rapid and efficient primary hepatocyte isolation protocol was formulated. Within only ~35 min, this protocol could yield as much, if not more, healthy primary hepatocytes as other protocols. Further, glucose metabolism experiments performed using the isolated primary hepatocytes validated the usefulness of this protocol in in vitro liver metabolism studies. We also extensively reviewed and analyzed the significance and purpose of each step in this study so that future researchers can further optimize this protocol based on needs.

Wprowadzenie

The liver serves as one of the most important organs in the vertebrate body due to the vital role it plays in numerous life-supporting functions like food digestion, blood circulation, and detoxification. Usage of mouse primary hepatocyte in vitro culture is increasingly popular in studies of carbohydrate metabolism and hepatic carcinoma. Therefore, it is important to develop a convenient method for mouse primary hepatocyte isolation while maintaining its innate physiological function. Due to its function as a hub of glucose metabolism, the liver is also central to glucose production and storage1. Experiments with primary hepatocytes in vitro are a must to most glucose metabolism studies. Therefore, for years, various research groups have developed protocols for mouse primary hepatocyte isolation.

The general procedure of mouse hepatocyte isolation is to first flush out blood in the liver with an isosmotic liquid such as phosphate-buffered saline (PBS) or Hanks' Balanced Salt Solution (HBSS) and then use collagenase-containing solution to dissociate hepatocytes. These protocols share a general procedure but differ in reagents and steps based on different needs. However, preparing required reagents and performing isolation steps take time. In developing the present protocol, efficiency was set as a priority, with all reagents ready-to-use and available from the market, and as few steps as possible. The overall goal of this protocol is to provide a fast and labor-efficient method to isolate primary hepatocytes from mouse, without jeopardizing the isolated primary hepatocyte purity and viability.

Protokół

All procedures were approved by the Johns Hopkins Animal Care and Use Committee. C57BL/6 female mice (8-week old) were used in this study.

1. Preparation:

  1. Mix William's E Medium (GlutaMAX Supplement) with 10% FBS and 1% antibiotic-antimycotic solution to make the culture medium.
  2. Filter 25 mL of collagenase-dispase medium (e.g., Liver Digest Medium) through a 0.45 µm syringe filter to remove particle debris.
  3. Warm 50 mL of double-distilled H2O (ddH2O), 35 mL of perfusion Medium (e.g., Liver Perfusion Medium) (or 50 mL at the first time using this protocol), and 25 mL of filtered collagenase-dispase medium in a 45 °C water bath for 30 min.
  4. Within a sterile tissue culture hood, mix 2 mL of 10x HBSS and 18 mL of Percoll in a 50 mL tube to make 20 mL 1x Percoll-HBSS and keep on ice or 4 °C.
    NOTE: 1x Percoll-HBSS can be kept at 4 °C for at least 6 months.
  5. Within a sterile tissue culture hood, pour 30 mL of wash medium (e.g., Hepatocyte Wash Medium) into a clean Petri dish, and keep on ice.
  6. Submerge the pumping tube in the water of a 45 °C water bath. Results are most reliable if the room temperature is at 25 °C.
  7. Prepare 2 mL of 1x anesthetics by mixing 225 µL of Ketamine HCL, 93.75 µL of Xylazine, and 1681 µL of 1x PBS.
  8. Anesthetize one mouse using an approved method. Here the mouse was intraperitoneally injected with 150 µL of 1x anesthetics. Perform the tests for loss of reflexes such as reaction to toe pinching to ensure full anesthesia.
  9. Secure the mouse on its back onto the dissection pad by four limbs, by either pining or using water-proof tape or other methods approved by the institution's Animal Care and Use Committee (or equivalents).
  10. Prepare sterilized forceps and scissors for dissection. To avoid possible contamination, conduct all steps within a sterile hood.

2. Procedure:

  1. Using a peristaltic pump, start pumping warmed-up ddH2O at a speed of 4 mL/min for 5 min. Change the pumping tube from water to a warmed-up perfusion medium.
  2. Disinfect the anesthetized mouse's abdomen with 70% EtOH and cut open with a scissor to expose the liver, portal vein, and inferior vena cava (IVC).
  3. Stop the peristaltic pump. Insert a 24 G catheter (e.g., Closed IV Catheter, 24 G, 0.75 IN) into IVC. Start pumping and cut the portal vein open.
  4. Continue pumping until the flushed-out liquid is clear (around 3-5 min). Press the portal vein every minute to let liquid reach every corner of the liver. Be careful not to let air bubbles enter the IVC.
    NOTE: This step is to flush out as much blood as possible from the liver.
  5. Change the pumping tube from the perfusion medium to the collagenase-dispase medium. Continue pumping until all 25 mL of the collagenase-dispase medium is depleted while doing step 2.6.
  6. Press the portal vein every minute to let liquid reach every corner of the liver.
    NOTE: At this stage, the complete loss of blood is fatal to the mouse. The death of the mouse can be confirmed by a lack of heartbeat after the experiment. Dispose of the carcass as per facility policies.
  7. Isolate the whole liver out without gallbladder to the 30 mL wash medium in the Petri dish on ice.
  8. Tear it up into pieces with forceps to release primary hepatocytes into solution. This step would turn the wash medium into a cloudy solution full of released primary hepatocytes and small liver pieces.
  9. Filter the cloudy solution in step 2.8 through a 70 µm cell strainer into the 20 mL 1x Percoll-HBSS in a 50 mL tube on ice. Mix by inverting the tube 20 times.
  10. Centrifuge at 300 x g for 10 min at 4 °C.
  11. Within the tissue culture hood, aspirate the supernatant. Wash the pellet with cold 30 mL of wash medium.
  12. Centrifuge at 50 x g for 5 min at 4 °C.
  13. Remove the supernatant and resuspend the pellet in 25 mL of the culture medium (or appropriate other volumes) within the tissue culture hood.
  14. Count the cell number and plate the cells on desired culture plates according to the experimental design.
    NOTE: Primary hepatocytes properly isolated from one 8-week-old mouse are usually sufficient to be plated on four 6-well plates or four 12-well plates.

Wyniki

In order to test the efficiency, the present primary hepatocyte isolation protocol was performed on 8-week old female C57BL/6 mice. The attachment and purity of isolated primary hepatocytes were tested. Primary hepatocyte isolation is used for a wide variety of experiments on liver physiology, such as hepatic drug effects and glucose metabolism, pharmaceutical biomarker activity2, insulin sensitivity, and glucose production. Therefore, the activities of the primary hepatocytes isolated with this p...

Dyskusje

Various primary hepatocyte isolation protocols have been developed. They also have been kept optimized and adapted based on different needs (Table 1). Isolation protocols are generally composed of two parts: perfusion (including enzyme digestion) and purification.

The perfusion can be performed with the entire liver in vivo2,20,21,22,

Ujawnienia

The authors have nothing to disclose.

Podziękowania

This work was supported by the National Institutes of Health (Grant 5R01HD095512-02 to S.W.).

Materiały

NameCompanyCatalog NumberComments
1x PBSGibco10010023
10x HBSSGibco14065-056
12-well PlateFALCON353043Coating not required
6-well PlateFALCON353046Coating not required
anti-AKTCell Signaling2920S
Antibiotic Antimycotic Solution (100x), StabilizedSigma-AldrichA5955
anti-FOXO1Cell Signaling97635S
anti-GAPDHCell Signaling2118S
anti-p-AKT (S473)Cell Signaling9271L
anti-PEPCKSanta CruzSC-166778
anti-p-FOXO1 (S256)Cell Signaling84192S
Cell Strainer, 70 µmCELLTREAT229483
Closed IV Catheter, 24 Gauge 0.75 INBecton Dickinson383511
DMEM, no glucose, no glutamine, no phenol redThermoFisher ScientificA1443001
EnzyChrom Glucose Assay KitBioAssay SystemsEBGL-100
Fetal Bovine Serum (FBS)HycloneSH30071.03
ForskolinMilliporeSigmaF3917-10MG
GlucagonSigma-AldrichG2044
Goat Anti-mouse IgG Secondary AntibodyLI-COR926-68070
Goat Anti-rabbit IgG Secondary AntibodyLI-COR926-32211
GraphPad Prism 8GraphPad SoftwareNA
Hepatocyte Wash MediumGibco17704-024
IBMXCell Signaling13630S
InsulinLillyNDC 0002-8215-01
Ketamine HCL (100 mg/mL)Hospira IncNDC 0409-2051-05
L-GlutamineGibco25030081
Liver Digest MediumGibco17703-034Aliquot within tissue culture hood to 25 mL each in 50 mL tube, and keep in -20 °C freezer
Liver Perfusion MediumGibco17701-038
Pen StrepGibco15140122
PercollGE Healthcare17-0891-01
Peristaltic PumpGilsonMinipuls 2Capable of pumping at 4 mL/min
Petri DishFisherbrand08-757-12
Refrigerated CentrifugeSorvallLegend RTCapable to centrifuge 50 mL tube at 4 °C
Sodium L-LactateSigma-AldrichL7022
Sodium PyruvateGibco11360070
Syringe Filter, PVDF 0.45 µm 30mm diameterCELLTREAT229745
Syringe, 0.5 mLBecton Dickinson329461
Syringe, 60 mLBecton Dickinson309653
Trypan Blue Solution, 0.4%Gibco15250061
Tube, 15 mLCorning430052
Tube, 50 mLCorning430290
Water Bath TankCorningCLS6783Or any water bath tank capable of heating up to 45 °C
William’s E Medium (GlutaMAX Supplement)Gibco32551020
Xylozine (100 mg/mL)Vetone Anased LANDC13985-704-10

Odniesienia

  1. Han, H. S., Kang, G., Kim, J. S., Choi, B. H., Koo, S. H. Regulation of glucose metabolism from a liver-centric perspective. Experimental and Molecular Medicine. 48, 218 (2016).
  2. Severgnini, M., et al. A rapid two-step method for isolation of functional primary mouse hepatocytes: cell characterization and asialoglycoprotein receptor based assay development. Cytotechnology. 64 (2), 187-195 (2012).
  3. Guidotti, J. E., et al. Liver cell polyploidization: a pivotal role for binuclear hepatocytes. Journal of Biological Chemistry. 278 (21), 19095-19101 (2003).
  4. Morales-Navarrete, H., et al. A versatile pipeline for the multi-scale digital reconstruction and quantitative analysis of 3D tissue architecture. Elife. 4, 11214 (2015).
  5. Bruening, J., et al. Hepatitis C virus enters liver cells using the CD81 receptor complex proteins calpain-5 and CBLB. PLoS Pathogens. 14 (7), 1007111 (2018).
  6. Silvie, O., et al. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity. Nature Medicine. 9 (1), 93-96 (2003).
  7. Crispe, I. N. Hepatocytes as immunological agents. Journal of Immunology. 196 (1), 17-21 (2016).
  8. Liu, N. C., et al. Loss of TR4 orphan nuclear receptor reduces phosphoenolpyruvate carboxykinase-mediated gluconeogenesis. Diabetes. 56 (12), 2901-2909 (2007).
  9. Wang, Z., et al. Gonadotrope androgen receptor mediates pituitary responsiveness to hormones and androgen-induced subfertility. JCI Insight. 5 (17), 127817 (2019).
  10. Santos, S. D., et al. CSF transthyretin neuroprotection in a mouse model of brain ischemia. Journal of Neurochemistry. 115 (6), 1434-1444 (2010).
  11. Pinhu, L., et al. Overexpression of Fas and FasL is associated with infectious complications and severity of experimental severe acute pancreatitis by promoting apoptosis of lymphocytes. Inflammation. 37 (4), 1202-1212 (2014).
  12. Mi, Y., Lin, A., Fiete, D., Steirer, L., Baenziger, J. U. Modulation of mannose and asialoglycoprotein receptor expression determines glycoprotein hormone half-life at critical points in the reproductive cycle. Journal of Biological Chemistry. 289 (17), 12157-12167 (2014).
  13. Tanowitz, M., et al. Asialoglycoprotein receptor 1 mediates productive uptake of N-acetylgalactosamine-conjugated and unconjugated phosphorothioate antisense oligonucleotides into liver hepatocytes. Nucleic Acids Research. 45 (21), 12388-12400 (2017).
  14. Manczak, M., et al. Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease. Human Molecular Genetics. 18 (20), 3876-3893 (2009).
  15. Zhang, Y., et al. JAK1-dependent transphosphorylation of JAK2 limits the antifibrotic effects of selective JAK2 inhibitors on long-term treatment. Annals of the Rheumatic Diseases. 76 (8), 1467-1475 (2017).
  16. Shih, S. C., et al. Molecular profiling of angiogenesis markers. American Journal of Pathology. 161 (1), 35-41 (2002).
  17. Liu, G., et al. miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proceedings of the National Academy of Sciences of the United States of America. 106 (37), 15819-15824 (2009).
  18. Ding, Q., et al. Mice expressing minimally humanized CD81 and occludin genes support Hepatitis C virus uptake in vivo. Journal of Virology. 91 (4), 01799 (2017).
  19. Renshaw, M., et al. Cutting edge: impaired Toll-like receptor expression and function in aging. Journal of Immunology. 169 (9), 4697-4701 (2002).
  20. Li, W. C., Ralphs, K. L., Tosh, D. Isolation and culture of adult mouse hepatocytes. Methods in Molecular Biology. 633, 185-196 (2010).
  21. Salem, E. S. B., et al. Isolation of primary mouse hepatocytes for nascent protein synthesis analysis by non-radioactive l-azidohomoalanine labeling method. Journal of Visualized Experiments: JoVE. (140), e58323 (2018).
  22. Cabral, F., et al. Purification of Hepatocytes and Sinusoidal Endothelial Cells from Mouse Liver Perfusion. Journal of Visualized Experiments: JoVE. (132), e56993 (2018).
  23. Korelova, K., Jirouskova, M., Sarnova, L., Gregor, M. Isolation and 3D collagen sandwich culture of primary mouse hepatocytes to study the role of cytoskeleton in bile canalicular formation in vitro. Journal of Visualized Experiments: JoVE. (154), e60507 (2019).
  24. Goncalves, L. A., Vigario, A. M., Penha-Goncalves, C. Improved isolation of murine hepatocytes for in vitro malaria liver stage studies. Malar Journal. 6, 169 (2007).
  25. Yin, Z., Ellis, E. C., Nowak, G. Isolation of mouse hepatocytes for transplantation: a comparison between antegrade and retrograde liver perfusion. Cell Transplant. 16 (8), 859-865 (2007).
  26. . Hepatocyte media, Thermofisher Available from: https://assets.thermofisher.com/TFS-Assets/LSG/manuals/Hepatocyte_Media_UG.pdf (2021)
  27. Sia, D., Villanueva, A., Friedman, S. L., Llovet, J. M. Liver cancer cell of origin, molecular class, and effects on patient prognosis. Gastroenterology. 152 (4), 745-761 (2017).
  28. Freitas-Lopes, M. A., Mafra, K., David, B. A., Carvalho-Gontijo, R., Menezes, G. B. Differential location and distribution of hepatic immune cells. Cells. 6 (4), 48 (2017).
  29. Schachtrup, C., Le Moan, N., Passino, M. A., Akassoglou, K. Hepatic stellate cells and astrocytes: Stars of scar formation and tissue repair. Cell Cycle. 10 (11), 1764-1771 (2011).
  30. Geerts, A. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Seminars in Liver Disease. 21 (3), 311-335 (2001).
  31. Poisson, J., et al. Liver sinusoidal endothelial cells: Physiology and role in liver diseases. Journal of Hepatology. 66 (1), 212-227 (2017).
  32. Peter, M. E., et al. The CD95 receptor: apoptosis revisited. Cell. 129 (3), 447-450 (2007).
  33. Peters, D. T., et al. Asialoglycoprotein receptor 1 is a specific cell-surface marker for isolating hepatocytes derived from human pluripotent stem cells. Development. 143 (9), 1475-1481 (2016).
  34. Willoughby, J. L. S., et al. Evaluation of GalNAc-siRNA conjugate activity in pre-clinical animal models with reduced asialoglycoprotein receptor expression. Molecular Therapy. 26 (1), 105-114 (2018).
  35. Hutchins, N. A., Chung, C. S., Borgerding, J. N., Ayala, C. A., Ayala, A. Kupffer cells protect liver sinusoidal endothelial cells from Fas-dependent apoptosis in sepsis by down-regulating gp130. American Journal of Pathology. 182 (3), 742-754 (2013).

Przedruki i uprawnienia

Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE

Zapytaj o uprawnienia

Przeglądaj więcej artyków

Mouse Primary HepatocytesLiver StudiesGlucose MetabolismHepatic Drug TestingIsolation ProtocolPeristaltic PumpPerfusion MediumCollagenase Dispase MediumCell StrainerTissue Culture HoodCentrifugeCell Pellet

This article has been published

Video Coming Soon

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone